Reboxetine for Central Pain: A Single-Blind Prospective Study
- 1 July 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 25 (4) , 238-239
- https://doi.org/10.1097/00002826-200207000-00009
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neuronsEuropean Journal of Neuroscience, 2001
- Reboxetine: the first selective noradrenaline re-uptake inhibitorExpert Opinion on Pharmacotherapy, 2000
- The neurochemistry of central pain: evidence from clinical studies, hypothesis and therapeutic implicationsPain, 1998
- Effects of Desipramine, Amitriptyline, and Fluoxetine on Pain in Diabetic NeuropathyNew England Journal of Medicine, 1992
- ROLE OF SPINAL NORADRENERGIC SYSTEM IN TRANSMISSION OF PAIN IN PATIENTS WITH SPINAL CORD INJURYThe Lancet, 1986